With early efforts directed to increasing intrinsic KCC2 activity and membrane trafficking showing some promise76,77, it is anticipated that further understanding of the KCC2 mechanisms will lead to novel development of therapeutic approaches to associated neurological disorders. Here, SLC12A5 is linked to nervous system disorder.